查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血液製品全球市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1264213

血液製品全球市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Blood Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 105 Pages | 商品交期: 最快1-2个工作天内

价格

血液製品是指从人体血液中提取的任何药物，包括全血、输血用血液成分和血浆衍生药物化合物。 每年，安全、有效和有质量保证的血液产品通过解决儿童死亡率和孕产妇健康这两个最紧迫的问题来改善或挽救数百万人的生命。 血液製品是从供体中提取供患者使用的血液成分或部分。 并非所有患者都需要完全输血，通常只需要输一些血液成分。 在这种情况下，从全血中提取特定的血液成分。 血液製品包括血小板、红细胞（RBC）、白细胞（WBC）、新鲜冰冻血浆（FFP）、凝血因子等血液製品。 某些血液製品根据人的情况给予。

市场动态：

由于血液相关疾病的患病率上升以及对血液相关产品的需求增加，血液製品市场正在增长。 此外，血液製品市场受到不断扩大的老年人口的推动。 同样，提供测试试剂、筛选设备和系统以对捐献的血液进行测试的重要市场参与者推动了血液製品市场。 此外，由于世界人口老龄化加剧以及政府对血液筛查的倡议和法规，预计血液製品市场将会增长。 促进市场迅速扩大的另一个方面是公众对献血的认识不断提高。 此外，对血液和血浆的需求增加正在推动对血液製品的需求。 然而，增强血液采集的高成本和缺乏经验丰富的实验室人员限制了市场扩张。

研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还提供了对全球血液製品市场各个部分的全面评估。 血液製品行业的发展和趋势为这项研究提供了一个整体的方法。

市场细分：

血液製品市场细分提供按国家和地区划分的详细数据，以帮助确定产品和服务的目标受众和未来商机。

按产品类型

  • 血小板
  • 新鲜冰冻血浆 (FFP)
  • 红细胞 (RBCS)
  • 白细胞 (WBCS)
  • 其他

按最终用途

  • 医院
  • 血站
  • 其他

按地区分析：

本部分涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲血液製品市场当前和未来的需求。 此外，它还关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 血液製品市场的主要参与者有 CSL、Octapharma AG、Kedrion S.p.A、Mitsubishi Tanabe Pharma Corporation、BPL Inc. 等。 本节全面介绍了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

如果您有任何定制要求，请写信给我们。 我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

  • 报告内容
    • 目的
    • 目标受众
    • USP（独特的销售建议）及其提供的内容
  • 调查范围
  • 调查方法
    • 市场调研流程
    • 市场研究方法

第 2 章执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章血液製品 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场製约因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按产品类型
    • 按最终用途
    • 按地区

第四章价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料製造商名单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章血液製品的全球市场分析：按产品类型

  • 摘要：按产品类型
  • 过去和未来的数据
  • 分析：按产品类型
  • 血小板市场：按地区
  • 新鲜冷冻血浆 (FFP) 市场：按地区
  • 红细胞 (RBC) 市场：按地区
  • 白细胞 (WBC) 市场：按地区
  • 其他市场：按地区

第 7 章全球血液製品市场最终用途分析

  • 按最终用途汇总
  • 过去和未来的数据
  • 最终用途分析
  • 医院市场：区域细分
  • 血站市场：按地区
  • 其他市场：按地区

第 8 章全球血液製品市场分析：按地区

  • 区域展望
  • 简介
  • 北美
    • 摘要、实际数据、预测数据
    • 按北美细分
    • 北美：按国家/地区列出
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 摘要、实际数据、预测数据
    • 欧洲（按细分市场）
    • 欧洲：按国家/地区分类
    • 英国
    • 法国
    • 德国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 摘要、实际数据、预测数据
    • 亚太区信息
    • 亚太地区：国家/地区信息
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 拉丁美洲
    • 摘要、实际数据、预测数据
    • 拉丁美洲细分市场
    • 拉丁美洲：按国家/地区列出
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲地区
  • 中东和非洲
    • 摘要、实际数据、预测数据
    • 中东和非洲分部信息
    • 中东和非洲：按国家/地区列出
    • 沙特阿拉伯
    • 阿联酋
    • 以色列
    • 南非
    • 其他中东和非洲地区

第9章血液製品厂商的竞争格局

  • 血液製品的市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他扩展

第十章公司简介

  • 公司股票分析
  • 市场集中度
  • 中超
    • 公司简介
    • 产品介绍
    • 近期趋势
  • Octapharma 公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • Kedrion S.p.A.
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 田边三菱製药公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • BPL 公司
    • 公司简介
    • 产品介绍
    • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

Product Code: VMR11217053

A blood product is any medicinal substance derived from human blood, such as whole blood and various blood components for transfusion and plasma-derived pharmaceutical compounds. Every year, safe, effective, and quality-assured blood products serve to improve and save millions of lives by addressing two pressing issues: child mortality and maternal health. A blood product is any component or part of blood extracted from a donor for use in patients. Not every patient requires a complete blood transfusion; many only require select blood components to be transfused. In such cases, specific blood components are extracted from the whole blood. Blood products include platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products. Depending on a person's condition, they are given a particular blood product.

Market Dynamics:

The market for blood products is growing due to the rising prevalence of blood-related ailments and the demand for blood-related goods. Furthermore, the market for blood products is being propelled ahead by the expanding older population. Again, significant market companies that provide reagents for testing, screening equipment, and systems to execute tests on donated blood are driving the blood product market. Furthermore, the blood products market is expected to grow as the global elderly population grows and government initiatives and regulations for blood screening. Another aspect contributing to the market's rapid expansion is increased public awareness regarding blood donation. Furthermore, increased demand for blood and plasma pushes demand for blood products. However, the high cost of enhanced blood collection and a scarcity of experienced laboratory personnel limit the market's expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of blood products. The growth and trends of blood products industry provide a holistic approach to this study.

Market Segmentation:

This section of the blood products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Platelets
  • Fresh Frozen Plasma (FFP)
  • Red Blood Cells (RBCS)
  • White Blood Cells (WBCS)
  • Others

By End-Use

  • Hospital
  • Blood Station
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Blood Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the blood products market include CSL, Octapharma AG, Kedrion S.p.A, Mitsubishi Tanabe Pharma Corporation, BPL Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BLOOD PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product Type
    • 3.7.2 By End-Use
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Platelets Market by Regions
  • 6.6 Fresh Frozen Plasma (FFP) Market by Regions
  • 6.5 Red Blood Cells (RBCs) Market by Regions
  • 6.7 White Blood Cells (WBCs) Market by Regions
  • 6.8 Others Market by Regions

7 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-Use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-Use
  • 7.4 Hospital Market by Regions
  • 7.5 Blood Station Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE BLOOD PRODUCTS COMPANIES

  • 9.1. Blood Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF BLOOD PRODUCTS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. CSL
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Octapharma AG
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Kedrion S.p.A.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Mitsubishi Tanabe Pharma Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. BPL Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Platelets Market by Geography (USD MN)
  • Fresh Frozen Plasma (FFP) Market by Geography (USD MN)
  • Red Blood Cells (RBCs) Market by Geography (USD MN)
  • White Blood Cells (WBCs) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by End-Use (USD MN)
  • Hospital Market by Geography (USD MN)
  • Blood Station Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Blood Products Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Blood Products Report
  • Market Research Process
  • Market Research Methodology
  • Global Blood Products Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Platelets Market by Geography (USD MN)
  • Fresh Frozen Plasma (FFP) Market by Geography (USD MN)
  • Red Blood Cells (RBCs) Market by Geography (USD MN)
  • White Blood Cells (WBCs) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospital Market by Geography (USD MN)
  • Blood Station Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.